Qairnel is spin off of the Paris Brain Institute. They are developing AI-based digital solutions to better detect and anticipate the progression of Alzheimer's disease. The technology developed by Qairnel will allow to better sort and stratify patients in order to obtain "Real World Evidence" that will allow to recommend more personalized treatments to patients.